Mudit K. Jain, Ph.D.
Mudit K. Jain, PhD is a General Partner at Synergy Life Science Partners and brings nearly two decades of experience in various functional and leadership roles in research, product development, business development, M&A, and venture capital. Mudit's career has been focused on identifying, developing, and investing in new medical device technologies serving large unmet clinical needs. Mudit brings a global perspective to Healthcare based on his experiences in US and India.
At Synergy, Mudit is responsible for sourcing opportunities, conducting diligence, executing transactions, serving on portfolio boards and fund administration, including but not limited to managing LP relationships and fund raising efforts. Mudit serves or served as a member of the Board of Directors of Aptus Endosystems (Acqd by Medtronic), Inspire Medical Systems, Neuspera, Inc., and NeuroTronik Limited, and is actively involved with iRhythm Technologies, (NSDQ: IRTC). Two of Mudit's investments were listed in the FierceMedicalDevices' 2014 Fierce 15, a recognition of the most promising private medical device companies that embody a huge leap forward.
Most recently, Mudit was with Johnson and Johnson Development Corporation (JJDC) as part of their management team and focused on all aspects of medical devices and diagnostics venture investments. Mudit led JJDC's medical device investments in the Midwest and East Coast with initial and follow-on investments in multiple device companies including CVRx, AngelMedical, GI Dynamics (ASX: GID), CardioMEMS (acqd: St. Jude Medical), and Impres Medical (acquired: Johnson and Johnson). Mudit also worked with Johnson and Jonson's medical device senior leadership on multiple strategic projects, and multi-billion dollar acquisitions. Prior to JJDC, Mudit was a Corporate Director with Corporate Office of Science and Technology at Johnson and Johnson. Before Johnson and Johnson, Mudit was with Guidant Corporation's Cardiac Rhythm Management Division and led the research and development of key technologies focused on cardiac ablation and cardiac resynchronization therapy. Mudit also played a key role in the early stage technology development for multiple venture backed medical device start-ups including Epicor, Inc. (acquired: St. Jude Medical), and Cardiac Pathways Corporation (acquired: Boston Scientific). Mudit holds eight issued patents and has published numerous articles in peer reviewed publications. Prior to his experiences in medical devices, Mudit worked in operational roles in petrochemical industry in India.
Mudit served as Chair of TiE (The Indus Entrepreneur) Silicon Valley, one of the largest entrepreneur network in Silicon Valley, from 2012-2014 and currently serves on the John Hopkins University Coulter Program Oversight Board, and on the Board of Visitors at Duke University's Graduate School.
Mudit graduated with a B.E. in Electrical Engineering from Regional Engineering College, Nagpur, India (ranked first in his class). He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.
Contact Mudit K. Jain